Paul S. Aisen

University of Southern California

NIH Rank #9
  • Top 1% Funded
  • R01 Holder
  • Multi-Institutional
  • Early Career

NIH Funding · FY2024

Total Funding
$59.4M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#9
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $59.4M across 5 grants · National rank #9.

Top grants by award amount

Paul S. Aisen's NIH grant portfolio, ranked by award amount.

  • 5U24AG057437-07U24
    Alzheimer's Clinical Trials Consortium (ACTC)
    $28.4M
    award amount
  • 5R01AG065248-03R01
    Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months
    $13.1M
    award amount
  • 5R01AG061848-05R01
    Combination anti-amyloid therapy for preclinical Alzheimer's disease
    $8.7M
    award amount
  • 5R01AG058468-04R01
    API A4 Alzheimer's Prevention Trial
    $6.5M
    award amount
  • 5R01AG063689-05R01
    Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
    $2.6M
    award amount

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Southern California
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    $25M Cumulative Funding
  8. 2024
    $50M Cumulative Funding
  9. 2024
    Entered Top 50% Nationally
    Ranked #9
  10. 2024
    Entered Top 25% Nationally
    Ranked #9
  11. 2024
    Entered Top 10% Nationally
    Ranked #9
  12. 2024
    Entered Top 5% Nationally
    Ranked #9
  13. 2024
    Entered Top 1% Nationally
    Ranked #9
  14. 2024
    Multi-Institutional Research
    Awards at 4 institutions